Search / Trial NCT06221579

An Intergenerational, Cognitively Enriched Intervention for MCI Patients and Their Children.

Launched by UNIVERSITY GHENT · Jan 12, 2024

Trial Information

Current as of October 07, 2024

Enrolling by invitation

Keywords

Description

In 2018, approximately 50 million people received a diagnosis of dementia, which is projected to triple by 2050. To mitigate the increase in dementia, it is crucial to prevent cognitive decline in at risk groups, such as older adults with mild cognitive impairment (MCI). Recent research has demonstrated that combining physical (PA) and cognitive activities yields positive effects on the cognitive health of older adults. However, it is essential to explore effective ways of implementing this approach for MCI patients as it may help prevent dementia. An intergenerational program offers a nov...

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • 1. MCI Diagnosis: Individuals with mild cognitive impairment (MCI) are eligible to participate, without a formal dementia diagnosis.
  • 2. MCI Type: Both amnestic and non-amnestic MCI individuals qualify for participation.
  • 3. Adult Child: Must have an adult child willing to participate in the program, free from serious health issues, both physically and cognitively.
  • Exclusion criteria:
  • 1. Dementia Diagnosis: Individuals formally diagnosed with dementia cannot participate.
  • 2. MCI from Specific Causes: Excludes those with MCI caused by frontotemporal dementia or Parkinson's.

About University Ghent

University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.

Locations

Ghent, , Belgium

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0